Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03315715 · ClinicalTrials.gov registry record
Dynamic Magnetic Resonance Imaging Before and After Vaginal Prolapse Repair
A clinical trial, sponsored by TriHealth.
- Completed
- Registry status
- 17
- Enrollment target
NCT03315715: Completed study, sponsored by TriHealth.
NCT03315715 is a clinical trial that has completed, run by TriHealth. The registered enrollment target is 17 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03315715 has completed, sponsored by TriHealth.
- COMPLETED
- Registry status
- 17 participants
- Enrollment target
Study Summary
This study is to describe the impact of vaginal reconstruction, including an intraperitoneal vaginal vault suspension for pelvic organ prolapse (POP) on pelvic anatomy using dynamic magnetic resonance imaging (MRI) of the pelvis.
Primary Outcome
The distance from pubic symphysis to the posterior anal canal
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2018-03-01 |
| Est. Completion | 2020-05-24 |
What the finished NCT03315715 record still lists
NCT03315715 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 17 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT03315715 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03315715 about?
NCT03315715 is a clinical study titled "Dynamic Magnetic Resonance Imaging Before and After Vaginal Prolapse Repair". This study is to describe the impact of vaginal reconstruction, including an intraperitoneal vaginal vault suspension for pelvic organ prolapse (POP) on pelvic anatomy using dynamic magnetic resonance imaging (MRI) of the pelvis.
What is the current status of trial NCT03315715?
This trial is currently completed. The enrollment target is 17 participants. The study started on 2018-03-01. Estimated completion is 2020-05-24.
Who is sponsoring clinical trial NCT03315715?
This trial is sponsored by TriHealth, which has 81 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02090140 · 17 participants · NA
Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects
- NCT03317860 · 17 participants · NA
Improving Measurement and Treatment of Post-stroke Neglect
- NCT04356469 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children
- NCT04414046 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI